Table 2.
p,p-DDE | PCB118 | |||||
---|---|---|---|---|---|---|
|
||||||
Mousea ng/g Silicone or Tissue |
Silicone Implants |
Predicted Adiposec |
Measured Ventral |
Silicone Implants |
Predicted Adiposec |
Measured Ventral |
| ||||||
31–70 | 660–1500 | 730–1200 | 20–110 | 550–3000 | 710–1300 | |
| ||||||
p,p-DDE | ||||||
|
||||||
Humanb ng/g Silicone or Tissue |
Silicone Implants |
Predicted Adiposec |
Predicted Adipose (using mouse data) |
Median (range) measured adipose tissue in literature
|
||
Tabasco, Mexicod (n=150) |
Granada Province, Spaine (n=387) |
Antwerp, Belgiumf (n=52) |
||||
| ||||||
1.2–34 | 25–680 | 26–740 | 877 (50–5000) | 93 (2.0–2300) | 141 (15–8399) |
Mouse implants included all those in the SIL treatment group
Human implants included all those containing p,p′-DDE
Based on Dlipid-silicone ≈ 21.2 for p,p-DDE, and ≈ 27.7 for PCB118 from (Jahnke et al. 2008)